MENU
VACBF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
NYKODE THERAPEUTICS AS (VACBF) Ownership - Who owns NYKODE THERAPEUTICS AS?
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies... Show more
Profile
Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
60.91M
P/E Ratio
N/A
Total Cash
106.23M
Projected Growth
N/A
Total Debt
3.28M
Revenue
7.85M
Risk (Beta)
N/A
Dividend Yield
0.49
Total Cash/Share
0.33
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
VACBF
Capitalization
60.9M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
0.49
Total Cash
106M
Total Cash/Share
0.33
Total Debt
3.28M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
7.85M
ROE
N/A
Book Value
134M
P/B Ratio
0.50
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
367K
Current Ratio
16.92
Current Revenue Per Employee
48726.62
Dividends Per Share - Security
N/A
EBITDA
-30.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.96
Shares Held By Institutions
38.8M
Shares Outstanding - Current
327M
Total Liabilities
12.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-15.033
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Gaustadalleen 21
Phone
+47 22958193
Employees
155
Web
https://www.nykode.com